Position in JNJ
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$2,057,157
+$26,839 QoQ
Shares Held
8,100
-2.5% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
2.68%
of 13F equity value
Holder Rank
#2,321
of 4,664 holders
Holding Since
Dec 2021
13 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Paradigm Capital Management, LLC/NV holds $8,119,187 across 5 Drug Manufacturers - General names. JNJ ranks #2 (25.3% of the industry book) .
All Filings in JNJ
Export CSV
13 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,057,157 | 8,100 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $2,030,318 | 8,306 | Shares | Sole | 2026-05-06 | |
| 2025-12-31 | $1,749,969 | 8,456 | Shares | Sole | 2026-02-06 | |
| 2025-09-30 | $1,576,997 | 8,505 | Shares | Sole | 2025-11-06 | |
| 2025-06-30 | $1,467,163 | 9,605 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $1,652,595 | 9,965 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $1,526,464 | 10,555 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $1,690,285 | 10,430 | Shares | Sole | 2024-11-14 | |
| 2022-12-31 | $1,782,751 | 10,092 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $1,650,262 | 10,102 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $1,828,708 | 10,302 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $1,843,546 | 10,402 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $1,781,180 | 10,412 | Shares | Sole | 2022-02-10 | |
| No filing history on record for this holder in this stock. | ||||||